CARRIE SMITH COX
CIK 1110753 · Executive Chair · last filed 2026-05-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$24.89M
Companies
11
Total Filings
117
Lifetime Open-Market Net
-$47.29M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Solventum Corp (SOLVw) Delisted | Director | 16,400 | — | — | $0 | 6 | 2026-05-18 |
| TXN | Director | 46,464 | $301.12 | $13.99M | -$17.25M | 42 | 2026-05-14 |
| OGN | Executive Chair | 90,338 | $13.44 | $1.21M | $602.3K | 7 | 2025-11-13 |
| RNAC | Director | 15,629 | $9.51 | $148.6K | $0 | 3 | 2025-01-06 |
| Cartesian Therapeutics, Inc. (SELB) Delisted | Director | 212,881 | $0.88 | $187.6K | $200.5K | 8 | 2023-01-04 |
| CAH | Director | 41,631 | $223.85 | $9.32M | $20.1K | 15 | 2022-11-10 |
| CELGENE CORP /DE/ (CELGZ) Delisted | Director | 0 | — | — | -$2.96M | 16 | 2019-11-22 |
| ECOR | Director | 21,000 | $10.25 | $215.2K | $118.7K | 4 | 2019-06-11 |
| CELGENE CORP /DE/ (CELG) Delisted | Director | 565 | — | — | $29.5K | 3 | 2010-06-18 |
| Merck & Co., Inc. (SGPpB) Delisted | Executive Vice President | 0 | — | — | $0 | 6 | 2009-11-04 |
| Merck & Co., Inc. (SGPpM) Delisted | Executive Vice President | 91,205 | — | — | -$28.06M | 2 | 2007-05-03 |
Recent Filings · Page 3 of 12
117 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-04 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-11-10 | CAH | Grant (A) | +2,308 | $0 | EDGAR |
| 2022-06-15 | Cartesian Therapeutics, Inc. (SELB) Delisted | Buy (P) | +130,000 | $149.8K | EDGAR |
| 2022-06-14 | OGN | Grant (A) | — | $0 | EDGAR |
| 2022-01-31 | TXN | Grant (A) | +572 | $0 | EDGAR |
| 2022-01-05 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-06 | Cartesian Therapeutics, Inc. (SELB) Delisted | Buy (P) | +17,200 | $50.7K | EDGAR |
| 2021-11-15 | CAH | Grant (A) | +3,709 | $0 | EDGAR |
| 2021-06-08 | OGN | Grant (A) | — | $0 | EDGAR |
| 2021-04-01 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.